SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:su-195242"
 

Search: onr:"swepub:oai:DiVA.org:su-195242" > Cyanobacteria-From ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Khalifa, Shaden A. M.Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut,Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden. (author)

Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021-04-24
  • MDPI AG,2021
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:su-195242
  • https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-195242URI
  • https://doi.org/10.3390/md19050241DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-446779URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:for swepub-publicationtype

Notes

  • Cyanobacteria are photosynthetic prokaryotic organisms which represent a significant source of novel, bioactive, secondary metabolites, and they are also considered an abundant source of bioactive compounds/drugs, such as dolastatin, cryptophycin 1, curacin toyocamycin, phytoalexin, cyanovirin-N and phycocyanin. Some of these compounds have displayed promising results in successful Phase I, II, III and IV clinical trials. Additionally, the cyanobacterial compounds applied to medical research have demonstrated an exciting future with great potential to be developed into new medicines. Most of these compounds have exhibited strong pharmacological activities, including neurotoxicity, cytotoxicity and antiviral activity against HCMV, HSV-1, HHV-6 and HIV-1, so these metabolites could be promising candidates for COVID-19 treatment. Therefore, the effective large-scale production of natural marine products through synthesis is important for resolving the existing issues associated with chemical isolation, including small yields, and may be necessary to better investigate their biological activities. Herein, we highlight the total synthesized and stereochemical determinations of the cyanobacterial bioactive compounds. Furthermore, this review primarily focuses on the biotechnological applications of cyanobacteria, including applications as cosmetics, food supplements, and the nanobiotechnological applications of cyanobacterial bioactive compounds in potential medicinal applications for various human diseases are discussed.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • El-Seedi, HeshamUppsala universitet,Farmakognosi,Menoufia Univ, Fac Sci, Dept Chem, Shibin Al Kawm 32512, Egypt.;Jiangsu Univ, Int Res Ctr Food Nutr & Safety, Zhenjiang 212013, Jiangsu, Peoples R China.(Swepub:uu)heels173 (author)
  • Saied, Essa M.Suez Canal Univ, Fac Sci, Chem Dept, Ismailia 41522, Egypt.;Humboldt Univ, Inst Chem, Brook Taylor Str 2, D-12489 Berlin, Germany. (author)
  • Jassbi, Amir RezaShiraz Univ Med Sci, Med & Nat Prod Chem Res Ctr, Shiraz 7134853734, Iran. (author)
  • Jamebozorgi, Fatemeh H.Shiraz Univ Med Sci, Med & Nat Prod Chem Res Ctr, Shiraz 7134853734, Iran. (author)
  • Rateb, Mostafa E.Univ West Scotland, Sch Comp Engn & Phys Sci, High St, Paisley PA1 2BE, Renfrew, Scotland. (author)
  • Du, MingDalian Polytech Univ, Natl Engn Res Ctr Seafood, Sch Food Sci & Technol, Dalian 116034, Peoples R China. (author)
  • Abdel-Daim, Mohamed M.Suez Canal Univ, Fac Vet Med, Pharmacol Dept, Ismailia 41522, Egypt. (author)
  • Kai, Guo-YinZhejiang Chinese Med Univ, Coll Pharm, Lab Med Plant Biotechnol, Hangzhou 311402, Peoples R China. (author)
  • Al-Hammady, Montaser A. M.NIOF, Natl Inst Oceanog & Fisheries, Cairo 11516, Egypt. (author)
  • Xiao, JianboJinan Univ, Inst Food Safety & Nutr, Guangzhou 510632, Peoples R China. (author)
  • Guo, ZhimingJiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Jiangsu, Peoples R China. (author)
  • El-Seedi, Hesham R. (author)
  • Stockholms universitetInstitutionen för molekylär biovetenskap, Wenner-Grens institut (creator_code:org_t)

Related titles

  • In:Marine Drugs: MDPI AG19:51660-3397

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view